302 related articles for article (PubMed ID: 26468825)
21. Oral cutaneous sinus tract, vertical root fracture, and bisphosphonate-related osteonecrosis: a case report.
Wigler R; Steinbock N; Berg T
J Endod; 2013 Aug; 39(8):1088-90. PubMed ID: 23880284
[TBL] [Abstract][Full Text] [Related]
22. Teriparatide therapy for bisphosphonate-related osteonecrosis of the jaw: a case report and narrative review.
Thumbigere-Math V; Gopalakrishnan R; Michalowicz BS
Northwest Dent; 2013; 92(1):12-8. PubMed ID: 23516715
[TBL] [Abstract][Full Text] [Related]
23. Further development of the MRONJ minipig large animal model.
Otto S; Pautke C; Martin Jurado O; Nehrbass D; Stoddart MJ; Ehrenfeld M; Zeiter S
J Craniomaxillofac Surg; 2017 Sep; 45(9):1503-1514. PubMed ID: 28803745
[TBL] [Abstract][Full Text] [Related]
24. Unusual case of a conservatively treated pathological fracture after sequestrectomy in a patient with long-term oral bisphosphonate use.
Kuijpers SC; van Roessel EW; van Merkesteyn JP
J Craniomaxillofac Surg; 2011 Jan; 39(1):69-72. PubMed ID: 20435482
[TBL] [Abstract][Full Text] [Related]
25. A case of early detection of bisphosphonate-related osteonecrosis of the jaw.
Mori M; Koide T; Matsui Y; Matsuda T
Indian J Pharmacol; 2015; 47(3):334-5. PubMed ID: 26069377
[TBL] [Abstract][Full Text] [Related]
26. Bisphosphonate-related osteonecrosis of the jaw in patients with oral bisphosphonate exposure: clinical course and outcomes.
O'Ryan FS; Lo JC
J Oral Maxillofac Surg; 2012 Aug; 70(8):1844-53. PubMed ID: 22595135
[TBL] [Abstract][Full Text] [Related]
27. Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: A trigger for BRONJ development?
Otto S; Tröltzsch M; Jambrovic V; Panya S; Probst F; Ristow O; Ehrenfeld M; Pautke C
J Craniomaxillofac Surg; 2015 Jul; 43(6):847-54. PubMed ID: 25958767
[TBL] [Abstract][Full Text] [Related]
28. Medication-related osteonecrosis of the jaws from once per year intravenous zoledronic acid (Reclast): report of 4 cases.
Lee CY; Suzuki JB
Implant Dent; 2015 Apr; 24(2):227-31. PubMed ID: 25734948
[TBL] [Abstract][Full Text] [Related]
29. Primary wound closure after tooth extraction for prevention of medication-related osteonecrosis of the jaw in patients under denosumab.
Matsumoto A; Sasaki M; Schmelzeisen R; Oyama Y; Mori Y; Voss PJ
Clin Oral Investig; 2017 Jan; 21(1):127-134. PubMed ID: 26924135
[TBL] [Abstract][Full Text] [Related]
30. [Position paper on medication-related osteonecrosis of the jaw (MRONJ)].
Svejda B; Muschitz Ch; Gruber R; Brandtner Ch; Svejda Ch; Gasser RW; Santler G; Dimai HP
Wien Med Wochenschr; 2016 Feb; 166(1-2):68-74. PubMed ID: 26847441
[TBL] [Abstract][Full Text] [Related]
31. Successful long-term mandibular reconstruction and rehabilitation using non-vascularised autologous bone graft and recombinant human BMP-7 with subsequent endosseous implant in a patient with bisphosphonate-related osteonecrosis of the jaw.
Rahim I; Salt S; Heliotis M
Br J Oral Maxillofac Surg; 2015 Nov; 53(9):870-4. PubMed ID: 26392134
[TBL] [Abstract][Full Text] [Related]
32. Successful treatment of osteonecrosis-induced fractured mandible with teriparatide therapy: A case report.
Yao M; Shimo T; Ono Y; Obata K; Yoshioka N; Sasaki A
Int J Surg Case Rep; 2016; 21():151-3. PubMed ID: 26947555
[TBL] [Abstract][Full Text] [Related]
33. Disease Stage and Mode of Therapy Are Important Determinants of Treatment Outcomes for Medication-Related Osteonecrosis of the Jaw.
Ruggiero SL; Kohn N
J Oral Maxillofac Surg; 2015 Dec; 73(12 Suppl):S94-S100. PubMed ID: 26608159
[TBL] [Abstract][Full Text] [Related]
34. [A case report - bisphosphonate-related osteonecrosis of the jaw(stage 0)successfully treated with sitafloxacin].
Ikeda T; Kohno N
Gan To Kagaku Ryoho; 2012 Dec; 39(13):2573-5. PubMed ID: 23235183
[TBL] [Abstract][Full Text] [Related]
35. Perioperative discontinuation of intravenous bisphosphonate therapy reduces the incidence and severity of bisphosphonate-related osteonecrosis of the jaw: A randomized, controlled, prospective experimental study in rats.
Zandi M; Dehghan A; Ghadermazi K; Malekzadeh H; Akbarzadeh M
J Craniomaxillofac Surg; 2015 Nov; 43(9):1823-8. PubMed ID: 26355024
[TBL] [Abstract][Full Text] [Related]
36. Rescue bisphosphonate treatment of alveolar bone improves extraction socket healing and reduces osteonecrosis in zoledronate-treated mice.
Hokugo A; Kanayama K; Sun S; Morinaga K; Sun Y; Wu Q; Sasaki H; Okawa H; Evans C; Ebetino FH; Lundy MW; Sadrerafi K; McKenna CE; Nishimura I
Bone; 2019 Jun; 123():115-128. PubMed ID: 30926440
[TBL] [Abstract][Full Text] [Related]
37. Multiple myeloma vs. breast cancer patients with bisphosphonates-related osteonecrosis of the jaws: a comparative analysis of response to treatment and predictors of outcome.
Fortuna G; Ruoppo E; Pollio A; Aria M; Adamo D; Leuci S; Orabona GD; Mignogna MD
J Oral Pathol Med; 2012 Mar; 41(3):222-8. PubMed ID: 22092390
[TBL] [Abstract][Full Text] [Related]
38. Distinctive role of 6-month teriparatide treatment on intractable bisphosphonate-related osteonecrosis of the jaw.
Kim KM; Park W; Oh SY; Kim HJ; Nam W; Lim SK; Rhee Y; Cha IH
Osteoporos Int; 2014 May; 25(5):1625-32. PubMed ID: 24554340
[TBL] [Abstract][Full Text] [Related]
39. Pathological fractures in patients caused by bisphosphonate-related osteonecrosis of the jaws: report of 3 cases.
Wongchuensoontorn C; Liebehenschel N; Wagner K; Fakler O; Gutwald R; Schmelzeisen R; Sauerbier S
J Oral Maxillofac Surg; 2009 Jun; 67(6):1311-6. PubMed ID: 19446222
[No Abstract] [Full Text] [Related]
40. Management of bisphosphonate-related osteonecrosis of the jaw: a literature review.
Spanou A; Lyritis GP; Chronopoulos E; Tournis S
Oral Dis; 2015 Nov; 21(8):927-36. PubMed ID: 25732104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
